Bafna Pharmaceuticals Limited Share Price NSE India S.E.
Equities
BAFNAPH
INE878I01014
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- INR | -.--% | +697.75% | +207.36% |
Sales 2022 | 851M 10.21M 817M | Sales 2023 | 1.15B 13.84M 1.11B | Capitalization | 1.94B 23.27M 1.86B |
---|---|---|---|---|---|
Net income 2022 | 51M 612K 48.97M | Net income 2023 | 113M 1.36M 108M | EV / Sales 2022 | 3.65 x |
Net Debt 2022 | 109M 1.31M 105M | Net Debt 2023 | 151M 1.81M 145M | EV / Sales 2023 | 1.81 x |
P/E ratio 2022 |
58.4
x | P/E ratio 2023 |
17.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 10.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 31/12/80 | |
M. Sridhar
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 31/12/80 | |
Krishna Yeachuri
BRD | Director/Board Member | 63 | 25/06/23 |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- BAFNAPH Stock
- BAFNAPH Stock